What dose of Mounjaro should I take?

Why does Mounjaro always start at 2.5 mg, even for people with a lot of weight to lose?

This is one of the most common questions our prescribers hear, and it comes with an understandable frustration: if the effective doses are higher, why start so low? The answer is in the gut. Tirzepatide activates two hormone receptors (GIP and GLP-1) both of which are involved in slowing gastric emptying. That is part of how it reduces appetite, but it is also why nausea and digestive discomfort are the most commonly reported early side effects. Starting at 2.5 mg gives your digestive system several weeks to adapt before anything is asked of it at a higher level.

The 2.5 mg dose exists primarily for your comfort and safety, not to produce measurable weight loss. Thinking of it as a settling-in period rather than an ineffective dose helps. Most people find the first four weeks manageable; some notice mild nausea in the day or two after each injection, which typically settles. The Mounjaro overview page covers what to expect during those early weeks in more detail.

Rushing the schedule does not improve outcomes, it increases the likelihood of side effects that might cause someone to stop treatment entirely. The NHS tirzepatide patient information published by NHS England supports this graduated approach, and it reflects what the clinical trial data showed across thousands of participants in the SURMOUNT programme.

When does the dose go up, and who decides?

Dose increases typically happen in four-week intervals, but that is a minimum, not a target. Your prescriber looks at how well the current dose is tolerated and whether there is a clinical reason to move up. If side effects are still present and disruptive, staying at the same strength for longer is a legitimate clinical choice, in fact it is often the right one.

At nume (sorry, at our pharmacy) every repeat order involves a clinical review before anything is dispensed. If a patient is requesting a higher strength, that request is assessed against what the evidence shows, not simply processed. This matters because dose escalation is not automatic and should not feel like a tick-box exercise. The question of whether to increase your Mounjaro dose is one with a real clinical answer that depends on your individual response.

There is a widespread misconception that higher always means better. The largest clinical trial in the SURMOUNT programme showed significant average weight loss at 10 mg and 12.5 mg, and many people find a dose well below 15 mg gives them what they need with fewer side effects. The goal is the dose that works for you, not the highest one available.

Is there a dose that most people end up on?

Trial data from SURMOUNT-1, published in the New England Journal of Medicine, showed dose-dependent weight loss: participants on 15 mg achieved an average reduction of around 20–21% of body weight over 72 weeks, with lower doses producing meaningful but somewhat smaller reductions. That said, individual responses vary considerably, and the figures come from a trial population, your experience will depend on your own biology, starting point and how you are eating alongside treatment.

Some people are maintained at 5 mg or 7.5 mg because that dose controls appetite well and is tolerated comfortably. Others titrate to the top. There is no universally "correct" dose. If you are curious about what a specific strength involves, the 5 mg pen page is a good place to start understanding what that step looks and feels like in practice, and questions about the concept of a so-called golden dose are worth exploring with your prescriber directly.

The cost of treatment does vary by dose, and if you want to understand how pricing works across the schedule, the Mounjaro prices page sets that out clearly. It is worth knowing before you start what the higher doses cost, so nothing comes as a surprise later.

What should I do if I feel ready to increase but my prescriber says to wait?

Trust the conversation. Prescribers who ask you to stay at your current dose are not being bureaucratic, they are looking at a fuller picture than the number on the scales. Perhaps side effects have not fully resolved, or the current dose has not had enough time to show its effect on your appetite and weight. Tirzepatide can continue working at a given strength for weeks after the body has adjusted to it.

If you feel the dose genuinely is not working for you, that is worth raising in your next review. Bring specifics: how your appetite has changed, whether nausea has settled, how your weight has moved over the last few weeks. A prescriber can give a better-informed answer when they have more to work with. You can also read more about going up a dose on Mounjaro and what that decision typically involves. NICE guidance on tirzepatide (TA1026) notes that if less than 5% weight loss has been achieved after six months at the highest tolerated dose, continuing treatment would be reconsidered, which underlines that the goal is always the most effective well-tolerated dose, assessed properly over time.

If you have questions or want to start treatment with a prescriber who will review every stage of your dose journey, speak to our prescribers through a free consultation.